Saul Shiffman1,2, Jeffrey M Rohay1,3, Deena Battista1, Judith P Kelly4, Mary K Malone5, Rachel B Weinstein6, David W Kaufman4. 1. Pinney Associates, Pittsburgh, PA, USA. 2. Department of Psychology, University of Pittsburgh, Pittsburgh, PA, USA. 3. School of Nursing, University of Pittsburgh, Pittsburgh, PA, USA. 4. Slone Epidemiology Center at Boston University, Boston, MA, USA. 5. Appleseed Consumer Insight, Arlington, MA, USA. 6. Janssen Research & Development, LLC, Titusville, NJ, USA.
Abstract
BACKGROUND: Acetaminophen overuse has been linked to liver injury. PURPOSE: To identify patterns of medication use associated with exceeding the recommended daily maximum dose of 4 g acetaminophen. METHODS: Respondents from a national panel completed a detailed daily medication diary online for 7 days (n = 5649), identifying medications taken from a comprehensive list of over-the-counter (OTC) and prescription (Rx) acetaminophen medications. Respondents were not told the study concerned acetaminophen. Total daily intake was calculated from diary data. Generalized estimating equations assessed the association of medication patterns with exceeding 4 g per day among 3618 respondents who used acetaminophen medications (on 13,852 days) during the diary period. RESULTS: Acetaminophen intake exceeded 4 g on 3.1% of usage days; median intake on those days was 5.5 g. As expected, days when intake exceeded 4 g were almost always (92%) marked by deviations from label directions-exceeding the one-time dose, re-dosing too soon, and concomitant use of multiple acetaminophen medications. Re-dosing too soon was the most frequent deviation, and concomitant use was most strongly tied to exceeding the daily limit. Use of both an Rx and an OTC medication on the same day also increased the odds of exceeding 4 g on days when concomitant use occurred. CONCLUSIONS: Excess dosing of acetaminophen is associated with deviations from label directions and by use of both OTC and Rx medications containing acetaminophen within a single concomitant use day.
BACKGROUND:Acetaminophen overuse has been linked to liver injury. PURPOSE: To identify patterns of medication use associated with exceeding the recommended daily maximum dose of 4 g acetaminophen. METHODS: Respondents from a national panel completed a detailed daily medication diary online for 7 days (n = 5649), identifying medications taken from a comprehensive list of over-the-counter (OTC) and prescription (Rx) acetaminophen medications. Respondents were not told the study concerned acetaminophen. Total daily intake was calculated from diary data. Generalized estimating equations assessed the association of medication patterns with exceeding 4 g per day among 3618 respondents who used acetaminophen medications (on 13,852 days) during the diary period. RESULTS:Acetaminophen intake exceeded 4 g on 3.1% of usage days; median intake on those days was 5.5 g. As expected, days when intake exceeded 4 g were almost always (92%) marked by deviations from label directions-exceeding the one-time dose, re-dosing too soon, and concomitant use of multiple acetaminophen medications. Re-dosing too soon was the most frequent deviation, and concomitant use was most strongly tied to exceeding the daily limit. Use of both an Rx and an OTC medication on the same day also increased the odds of exceeding 4 g on days when concomitant use occurred. CONCLUSIONS: Excess dosing of acetaminophen is associated with deviations from label directions and by use of both OTC and Rx medications containing acetaminophen within a single concomitant use day.
Authors: David W Kaufman; Judith P Kelly; Deena R Battista; Mary K Malone; Rachel B Weinstein; Saul Shiffman Journal: Br J Clin Pharmacol Date: 2019-03-18 Impact factor: 4.335
Authors: Saul Shiffman; Deena R Battista; Judith P Kelly; Mary K Malone; Rachel B Weinstein; David W Kaufman Journal: Br J Clin Pharmacol Date: 2018-03-25 Impact factor: 4.335
Authors: Junzhi Yang; Robert D Betterton; Erica I Williams; Joshua A Stanton; Elizabeth S Reddell; Chidinma E Ogbonnaya; Emma Dorn; Thomas P Davis; Jeffrey J Lochhead; Patrick T Ronaldson Journal: Pharmaceutics Date: 2022-04-27 Impact factor: 6.525